Financial intelligence for Asia's healthcare markets
Remember me:


Shares in Ramsay Health Care traded up more than 5% after Australian’s largest private hospital operator beat market expectations with a 16.8% jump in annual net profits to A$450.3 million (US$341.1 million). Revenues rose 18.1%, above guidance of 15-17% growth, to A$8.7 billion.
Global private equity firm CVC Capital Partners has bought a 15% stake in Siloam International Hospitals, Indonesia’s largest private hospital operator, for Rp2.2 trillion (US$165.9 million). It will manage this through share purchases from Siloam’s parent Lippo Karawaci and brokerage Ciptadana as well its participation in a proposed rights issue by Siloam.
SGX-listed healthcare provider Healthway Medical Corporation (HMC) plans to raise S$4 million (US$2.9 million) in a share placement, representing 5.73% of the company’s existing share capital. PrimePartners is acting as sponsor.
Hua Han Health Industry Holdings, which specialises in the investment and management of the medical industry, has stepped up its fight with equity analysts Emerson Analytics. It was a negative Emerson report that saw the stock of Hua Han suspended two weeks ago after falling almost a third to HK$0.47 (US$0.06).
Chinese precision cloud radiotherapy start-up Beijing Allcure Medical Technology has raised a Rmb180 million (US$27 million) Series A funding led by Zhengheci Capital and Lian Fund.
Brisbane-based DoseMe, a software developer that allows doctors to dose a patient based upon that patient’s individual ability to absorb, process, and clear a drug, has raised A$2.6 million (US$2 million) in Series A funding. The round was led by Gary Cunningham and Greg Spurgin, the CEO and COO of Results Physiotherapy.
Rici Healthcare, a private general medical services group in the Yangtze River Delta, has revived plans for an IPO. It pulled its up-to US$200 million IPO on the Hong Kong Stock Exchange at the end of June citing market conditions. BNP Paribas and Credit Suisse are the joint sponsors.
Moody’s Investors Service has assigned a first-time Ba3 corporate family rating to IVD and medical imaging company Yestar International Holdings.


China’s State Council has declared that healthcare big data is a fundamental, strategic national resource. Jun Wei and Roy Zou, partners at Hogan Lovells in Beijing, explain what the new regulations mean.
Elderly healthcare in the Asia Pacific region will cost more than US$20 trillion between 2015 and 2030, according to a new report released by professional services firm Marsh & McLennan Companies (MMC).
Michael Griffiths, regional director of healthcare at Aon Singapore, explains why the establishment of Singapore Medical Indemnity is important for doctors in the island state who want cover against malpractice claims.
Following the recent hack at the Hong Kong Department of Health which compromised up to 17,000 client files across four clinical services, Juni Yan, managing director, Hong Kong and Taiwan, F5 Networks, looks at IT security and healthcare.
Peter Zhang, chairman of Hong Kong-listed Hua Han Health Industry Holdings, which specialises in the investment and management of the medical industry, has said that he is “deeply shocked and furious” at allegations of financial impropriety by Emerson Analytics. He calls the charges of Rmb1.1 billion (US$16.6 million) fraud “malicious, untrue and groundless”.
The first half of the year has provided a distinctly mixed set of results for healthcare companies in Singapore. The economic backdrop has been, as almost all companies admit, tough. But some have succeeded. The standout winners, without a doubt, are Singapore O&G and Singapore Medical Group.
Trading in Hong Kong-listed Hua Han Health Industry Holdings, which specialises in the investment and management of the medical industry, has been suspended following allegations of financial impropriety by short-seller Emerson Analytics that call for the company to be delisted.
The trade sale for Oceania Healthcare, New Zealand’s second largest retirement village operator, is heating up. After flirting with an IPO two years ago and stumbling in its attempt at a trade sale last year, interest is growing for the latest attempt which is said to be worth around NZ$600 million (US$416 million).

HealthInvestor Asia twitter feed

HealthInvestor Asia Summit 2016


Asian stock markets were mostly lower today after a distinctly hawkish speech from US Federal Reserve chairwoman Janet Yellen. “I believe the case for an increase in the federal funds rate has strengthened in recent months,” she said at the Fed’s Jackson Hole conference on Friday. Are Asian markets getting ahead of themselves? Possibly. “This week’s key inflation and labour market updates will show us when – or if – the FOMC will walk the walk,” said Max McKegg, managing director of Technical Research in Wellington this afternoon. “In the meantime, FX traders have got the bit between their teeth and seem determined to front run the Fed,” he added. Most exchanges weakened in anticipation of fund flows out of emerging markets and into US dollar assets. The exception was the Nikkei which gained 2.30% as the yen weakened. The ASX was down 0.84%, the Shanghai Composite was off by 0.02% and the SGX declined 0.79%.

The Future of Healthcare in Asia

Round table

Download the round table here




HealthInvestor UK